Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
British Journal of Cancer|October 25, 2000
Autoimmunity against p53 predicts invasive cancer with poor survival in patients with an ovarian massF D Vogl, M Frey, R Kreienberg, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 12, 2015
Risk factors for bone pain among patients with cancer receiving myelosuppressive chemotherapy and pegfilgrastimH Xu, Q Gong, F D Vogl, et al.
British Journal of Cancer|November 26, 1999
Serum p53 autoantibodies in patients with minimal lesions of ductal carcinoma in situ of the breastS Regele, P Kohlberger, F D Vogl, et al.
International Journal of Molecular Medicine|October 13, 2000
Soluble CD44 splice variants and pelvic lymph node metastasis in ovarian cancer patientsE Stickeler, F D Vogl, T Denkinger, et al.
European Journal of Neurology|August 22, 2008
Adapted Finnish Migraine-Specific Questionnaire for family studies (FMSQ(FS)): a validation study in two languagesM F Facheris, F D Vogl, S Hollmann, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 19, 2004
Sentinel-node biopsy for axillary staging in breast cancer: results from a large prospective German multi-institutional trialT Kuehn, F D Vogl, G Helms, et al.
Annals of Human Genetics|October 19, 2006
Population isolates in South Tyrol and their value for genetic dissection of complex diseasesF Marroni, I Pichler, A De Grandi, et al.
The Journal of Clinical Endocrinology and Metabolism|November 10, 2001
Increased risk for nonmedullary thyroid cancer in the first degree relatives of prevalent cases of nonmedullary thyroid cancer: a hospital-based studyT Pal, F D Vogl, P O Chappuis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 2016
Health-related quality of life in women with recurrent ovarian cancer receiving paclitaxel plus trebananib or placebo (TRINOVA-1)K Fujiwara, B J Monk, C Lhommé, et al.
Pageof 1